当前位置: 首页 > 期刊 > 《中国保健营养·临床医学学刊》 > 2010年第11期 > 正文
编号:12029855
基质金属蛋白酶及其抑制物在宫颈癌表达的意义(2)
http://www.100md.com 2010年6月1日 韩国平 姜平
第1页

    参见附件(2635KB,3页)。

     [4] Liotta LA,Steeg PS and Stetler-Stevenson WG:Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation[J].Cell 1991,64:327-336.

    [5] Crawford HC and Matrisian LM:Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.Invasion Metastasis,1994,14:234-245.

    [6] Freije JM,Balbin M,Pendas AM,Sanchez LM,Puente XS and Lopez-Otin C:Matrix metalloproteinases and tumour progression.Adv Exp Med Biol, 2003,532:91-107.

    [7] 吴丹,李珊珊,张红燕,等.宫颈鳞癌组织中E一钙粘附素的表达[J].郑州大学学报(医学版),2004,39(3):373-375.

    [8] Grancotti FG,Ruoslahti E.Integrin Signaling F[J].Science,1999,285:1028-1033.

    [9] 0beIgA,HoyhtyaM,Tavehn B,et.Limited value of preoperative senrum analyses of matrix metaUoproteinases(MMP-2,MMP-9)and tissue inbitors of matrix metaUoproteinases(TIMP-1,TIMP-2)in colorectal callcer [J].Anticancer Res,2OOO,20(2B):1085-1091.

    [10] Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metaUoproteinase-2 inhibits bFGF-induced human microvascular endo- thehal cell proliferation[J].J cell Physiol,1993,157(2):351-358.

    [11] Kugler A.Matrix metalloproteinases and their inhibitors.Anti-cancer Res,1999,19(2C):1589-1592.

您现在查看是摘要介绍页,详见PDF附件(2635KB,3页)